Align Technology (ALGN) Cash from Investing Activities (2009 - 2026)
Align Technology's (ALGN) quarterly Cash from Investing Activities came in at -$131.6 million in Q1 2026, down 420.31% year-on-year from $41.1 million in Q1 2025, and down 266.36% on a QoQ basis from -$35.9 million in Q4 2025.
Align Technology (ALGN) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has 18 years of Cash from Investing Activities data on file, last reported at -$131.6 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 420.31% year-over-year to -$131.6 million in Q1 2026; TTM through Mar 2026 was -$218.7 million, a 9.03% decrease from a year earlier, with the FY2025 full-year figure at -$112.4 million, up 55.89% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$131.6 million, down from -$35.9 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ALGN reached as high as $18.1 million in Q2 2022 and fell as low as -$131.6 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$53.4 million across 5 years, with a median of -$52.8 million in 2023.
- On a YoY basis, Cash from Investing Activities climbed as much as 114.1% in 2022 and fell as far as 2075.43% in 2022.
- Year by year, Cash from Investing Activities stood at -$55.8 million in 2022, then soared by 76.13% to -$13.3 million in 2023, then sank by 304.65% to -$53.9 million in 2024, then surged by 33.39% to -$35.9 million in 2025, then tumbled by 266.36% to -$131.6 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$131.6 million in Q1 2026, -$35.9 million in Q4 2025, and -$19.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.58 Mn |
| Mar 31, 2026 | -131.58 Mn |
| Dec 31, 2025 | -35.92 Mn |
| Dec 31, 2025 | -35.92 Mn |
| Sep 30, 2025 | -19.76 Mn |
| Sep 30, 2025 | -19.76 Mn |
| Jun 30, 2025 | -31.48 Mn |
| Jun 30, 2025 | -31.48 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Mar 31, 2025 | -25.29 Mn |
| Dec 31, 2024 | -53.92 Mn |
| Dec 31, 2024 | -53.92 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Sep 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | -112.49 Mn |
| Jun 30, 2024 | -112.49 Mn |
| Mar 31, 2024 | -79.58 Mn |
| Mar 31, 2024 | -79.58 Mn |
| Dec 31, 2023 | -13.32 Mn |
| Dec 31, 2023 | -13.32 Mn |